In the post-September 11, 2001, environment, the U.S. Food and Drug Administration (FDA) faces many new challenges. On December 19, 2002, the RAND Center for Domestic and International Health Security hosted FDA leaders, Department of Defense officials, health policy analysts, and various others at a one-day workshop to discuss FDA’s role in homeland and national security. Participants analyzed how FDA might modify its policies and procedures to make drugs and biologics, and especially vaccines, more readily available.
